|
|
 |
 |
| Application deadline: January 24, 2025 |
 |
| Singapore QuickFire Challenge: Precision Immunology |
 |
Interested in the Singapore innovation ecosystem? Submit your potentially transformative precision medicine approaches for targeted therapies that can be applied across Immune-Mediated Diseases, including atopic Dermatitis, Hidradenitis Suppurativa, Inflammatory Bowel Disease (Ulcerative Colitis and Crohn’s disease), as well as rheumatic diseases (Rheumatoid Arthritis, Psoriatic Arthritis).
Apply now for the chance to receive grant funding, JLABS Singapore membership and mentorship! |
|
|
|
|
|
|
| Challenge awards1 |
 |
|
|
 |
|
| Grant funding from a total pool of US$200,000 |
|
 |
|
 |
|
| JLABS Singapore membership and access to the global Johnson & Johnson Innovation-JLABS network |
|
|
|
 |
|
| Mentorship from experts across Johnson & Johnson |
|
|
|
|
|
|
|
| Areas of interest |
 |
|
Specific Immune-Mediated Disease areas of interest include:
- Atopic Dermatitis
- Hidradenitis Suppurativa
- Inflammatory Bowel Disease
- Ulcerative Colitis
- Crohn’s disease
- Rheumatoid Arthritis
- Rheumatoid Arthritis
- Psoriatic Arthritis
|
|
|
|
|
|
|
|
 |
|
New to Johnson & Johnson Innovation or interested in more briefs?
|
|
|
|
|
|
|
|
|
|
|
© Johnson & Johnson Innovation 2024.
Johnson & Johnson Innovation
410 George Street
New Brunswick
NJ
08901
USA
You received this email because you are subscribed to QuickFire Challenges Brief from Johnson & Johnson Innovation.
Update your profile to choose the types of emails you receive or unsubscribe from future emails
This email is from Johnson & Johnson Innovation and represents a selection of activities from across our Innovation Centers, JLABS, and JJDC, as well as Johnson & Johnson Family of Companies. The information in this email is for informational purposes only. The information is either proprietary or licensed to Johnson & Johnson Innovation LLC, its parent company or any affiliate companies ("JJI and Johnson & Johnson") or is provided by or proprietary to third parties. In case of third party information, please note that only those third parties that provided or own this information are responsible for it. By providing this information, JJI and Johnson & Johnson do not endorse these third parties or any of the information provided in this email. This content is not intended to influence the use, sale, recommendation, or promotion of any products or services of JJI or Johnson & Johnson. JJI and Johnson & Johnson are not responsible or liable for any actions you do or do not take in relation to this information and are not responsible for any use of this information by you. By providing the information in this email, JJI and Johnson & Johnson do not make any representations, warranties, or assurances, express or implied, as to the content or the information presented in this email and is not responsible for any use by or alterations of this information by you. JJI and Johnson & Johnson hereby expressly disclaim any and all guarantees, representations, warranties, or assurances and assumes no responsibility or liability, direct or indirect in relation to the information in this email. |
|
|
|
